Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SODIUM IODIDE I 131

SODIUM IODIDE I-131

Standard Dose
250-1000mCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 213615 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 250-1000mCi Sponsor CARDINAL HLTH 414 Submission history Latest submission status date: 2025-06-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 213615 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SODIUM IODIDE I-131 Form and strength SOLUTION;ORAL - 250-1000mCi Sponsor CARDINAL HLTH 414 Submission history Latest submission status date: 2025-06-12 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.